New Flu Vaccine to Offer Better Protection

The two additional influenza strains are expected to be added to the vaccine in 2013.
Every year the Food and Drug Administration decides which strains of influenza should be included in the next flu vaccine. An FDA advisory panel recently recommended keeping one of the current strains and adding two new strains of influenza to the vaccine. The decision was based on trends and strains being seen other places in the world, such as the Southern Hemisphere.
However, it’s a new vaccine that has captured the attention of many, one that could offer better protection against more strains of the virus.
The new FluMist Quadrivalent will add an additional strain of influenza B to the vaccine. It’s the first flu vaccine to offer protection against four different strains of influenza.
“The current flu vaccine protects against three strains of the virus, two types of influenza A and one type of influenza B,” said Todd Bell, M.D., executive director of the West Texas Influenza Center.
“If you only protect against one strain of the virus, there’s a chance you’ll get the flu from another strain,” Bell said. “The idea of adding another strain of influenza B increases our chances of protection.”
The new vaccine isn’t expected to be available until 2013.
“For one, production of the next year’s vaccine is probably already under way,” Bell said. “Also, they still have to determine which strain of influenza B to include in the new vaccine.”
Each year, flu infections are associated with more than 100,000 hospitalizations and more than 10,000 deaths either directly from the flu or other causes including respiratory and circulatory complications
Bell said it’s important that people get their flu shots, regardless of which strains or how many are included in the vaccine.
“The key thing is that people need to get their flu shots,” he said. “If they do, we’ll save lives in the U.S.”
Related Stories
Molecular Pathology Preceptorship: Unmatched Value and Experience
Ericka Hendrix, PhD, MB(ASCP)CM, Program Director and Associate Professor in the Master of Science in Molecular Pathology program in the School of Health Professions spoke about the program’s preceptorship.
Moseley Named Permian Basin Regional Dean of the Texas Tech University Health Sciences Center School of Nursing
Kelly Moseley, DHSc, R.N., has been named the TTUHSC School of Nursing regional dean in the Permian Basin.
TTUHSC School of Nursing to Celebrate New YWCA Location
Community members in central Lubbock now have access to health care services and prenatal programs at one location inside the YWCA.
Recent Stories
Psychedelic Therapy: Jury’s Still Out
Dr. Michelle Shuler, an assistant professor in the Department of Clinical Counseling and Mental Health at TTUHSC, discussed psychedelic therapy.
TTUHSC’s Graduate School of Biomedical Sciences Hosts 37th Student Research Week
Student researchers from the Texas Tech University Health Sciences Center (TTUHSC) participated in the 37th Student Research Week Feb. 26-28.
Molecular Pathology Preceptorship: Unmatched Value and Experience
Ericka Hendrix, PhD, MB(ASCP)CM, Program Director and Associate Professor in the Master of Science in Molecular Pathology program in the School of Health Professions spoke about the program’s preceptorship.